Clinical Trial

Correlation Analysis Between Peripheral Blood PrPC Levels and Disease Severity and Prognosis in Patients With Acute Cerebral Infarction

Completed
View on ClinicalTrials.gov →
Summary
The primary objective of this observational study is to investigate alterations in PrPc levels in peripheral blood during acute cerebral infarction, as well as the correlation between these changes and both disease severity and prognosis. Additionally, it aims to explore the association between peripheral blood PrPc and T-cell-mediated inflammatory responses in acute cerebral infarction. Key research questions addressed include: how PrPc concentrations in peripheral blood change during acute cerebral infarction, and whether such variations correlate with clinical severity and patient outcomes. No interventions were administered in this study, and all patients received standard diagnostic and therapeutic care without disruption. Fasting venous blood samples were collected on the morning following hospital admission, and follow-up assessments using the modified Rankin Scale (mRS) were conducted at 90 days post-onset.
Trial Details
NCT Number NCT07513428
Lead Sponsor The First Hospital of Jilin University
Conditions Acute Cerebral Infarction
Enrollment 79 participants
Start Date 2023-06-06
Primary Completion 2024-06-03 (estimated)
Study Completion 2024-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-07